Clinicogenetic study of mutations inLRRK2 exon 41 in Parkinson's disease patients from 18 countries-Reference-Cited by-同舟云学术

Clinicogenetic study of mutations inLRRK2 exon 41 in Parkinson's disease patients from 18 countries

Published:2006 Issue:8 Volume:21 Page:1102-1108
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Tomiyama Hiroyuki,Li Yuanzhe,Funayama Manabu,Hasegawa Kazuko,Yoshino Hiroyo,Kubo Shin-Ichiro,Sato Kenichi,Hattori Tatsuya,Lu Chin-Song,Inzelberg Rivka,Djaldetti Ruth,Melamed Eldad,Amouri Rim,Gouider-Khouja Neziha,Hentati Faycal,Hatano Yasuko,Wang Mei,Imamichi Yoko,Mizoguchi Koichi,Miyajima Hiroaki,Obata Fumiya,Toda Tatsushi,Farrer Matthew J.,Mizuno Yoshikuni,Hattori Nobutaka

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference29 articles.

1. Parkinson's Disease

2. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

3. The ubiquitin pathway in Parkinson's disease

4. Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease

5. Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Genetic Architecture of Parkinson's Disease in the AfrAbia Population: Current State and Future Perspectives;Journal of Integrative Neuroscience;2024-08-19

2. LRRK2 Attenuates Antioxidant Response in Familial Parkinson’s Disease Derived Neural Stem Cells;Cells;2023-10-31

3. Overview of the Impact of Pathogenic LRRK2 Mutations in Parkinson’s Disease;Biomolecules;2023-05-16

4. Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease;Genes;2022-10-25

5. Review of the epidemiology and variability of LRRK2 non-p.Gly2019Ser pathogenic mutations in Parkinson’s disease;Frontiers in Neuroscience;2022-09-20